Melanoma Great Debate: Targeted versus complete nodal dissection following neoadjuvant therapy for melanoma: Is it time to push forward or hold off on continued de-escalation of surgery? Review


Authors: van Akkooi, A.; Ariyan, C.; Moncrieff, M.
Review Title: Melanoma Great Debate: Targeted versus complete nodal dissection following neoadjuvant therapy for melanoma: Is it time to push forward or hold off on continued de-escalation of surgery?
Abstract: The management of stage III melanoma has undergone profound change with the advent of effective systemic therapies and the growing use of neoadjuvant immunotherapy. This paper highlights the issues raised and points discussed during the Great Debates session at the 2024 SSO Conference in Atlanta, focusing on the necessity of therapeutic lymph node dissection (TLND) after index lymph node (ILN) surgery.
Keywords: lymphadenectomy; ipilimumab; melanoma; radiotherapy; high-risk; multicenter; completion lymphadenectomy; mm; nivolumab; stage-iii melanoma; excision margins; neoadjuvant systemic therapy; adjuvant dabrafenib
Journal Title: Annals of Surgical Oncology
ISSN: 1068-9265
Publisher: Springer  
Publication status: Online ahead of print
Date Published: 2025-08-29
Online Publication Date: 2025-08-29
Language: English
ACCESSION: WOS:001563300500001
DOI: 10.1245/s10434-025-18163-2
PROVIDER: wos
PUBMED: 40883533
Notes: Article; Early Access -- Source: Wos
Altmetric
Citation Impact
BMJ Impact Analytics
MSK Authors
  1. Charlotte Eielson Ariyan
    157 Ariyan
Related MSK Work